Advanced Search
Contact | Corporate | Help

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)

Sponsors:
  • Abbott
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Advanced Hepatocellular Carcinoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: ABT-869
Enrollment:
44

Additional information about NCT00517920.


SourceSolution © 2008-2012